The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Precision neoadjuvant therapy (P-NAT): A planned interim analysis of a randomized, TNBC enrolling trial to confirm molecular profiling improves survival (ARTEMIS).
 
Stacy L. Moulder
Honoraria - Novartis
Research Funding - Bayer (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Novartis
 
Kenneth R. Hess
No Relationships to Disclose
 
Rosalind P Candelaria
No Relationships to Disclose
 
Gaiane M Rauch
No Relationships to Disclose
 
Lumarie Santiago
No Relationships to Disclose
 
Beatriz Adrada
No Relationships to Disclose
 
Wei Tse Yang
Honoraria - Wolters Kluwer
Consulting or Advisory Role - GE Healthcare; Seno Medical
Patents, Royalties, Other Intellectual Property - Elsevier
 
Michael Z Gilcrease
No Relationships to Disclose
 
Lei Huo
No Relationships to Disclose
 
Michael Charles Stauder
Stock and Other Ownership Interests - Athersys
Speakers' Bureau - Varian Medical Systems
Research Funding - EMD Serono
 
Banu Arun
Research Funding - Abbvie; PharmaMar
 
Rachel M. Layman
Research Funding - Novartis; Pfizer
 
Rashmi Krishna Murthy
Consulting or Advisory Role - Daiichi Sankyo; Genentech
Research Funding - Daiichi Sankyo; Genentech/Roche; Merrimack (Inst); Oncothyreon (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Oncothyreon
 
Senthil Damodaran
No Relationships to Disclose
 
Naoto T. Ueno
Honoraria - Kyowa Hakko Kirin
Research Funding - Amgen; Bayer; Bio-Path Holdings; Celgene; Daiichi Sankyo; GlaxoSmithKline; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Puma Biotechnology
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Alastair Mark Thompson
Honoraria - Novartis (I)
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Novartis (I)
 
Bora Lim
No Relationships to Disclose
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - OBI Pharma; Peregrine Pharmaceuticals; TapImmune Inc.
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst)
 
Jennifer Keating Litton
Consulting or Advisory Role - Medivation; Novartis; Pfizer
Speakers' Bureau - Physicans' Education Resource; UpToDate; WebMD
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono; Genentech; GlaxoSmithKline; Jounce Therapeutics; medivation; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Medivation; pfizer; Physicans' Education Resource
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Intellectual property
Travel, Accommodations, Expenses - Luminex